C-reactive protein alterations in bipolar disorder: a meta-analysis

The Journal of Clinical Psychiatry
Aroldo A DargélMarion Leboyer

Abstract

There is growing evidence that bipolar disorder (BD) is associated with inflammation, including abnormal levels of acute-phase C-reactive protein (CRP). Our meta-analysis was conducted to estimate the size of the association between CRP levels and BD, accounting also for subgroup differences (mood phases and treatment). MEDLINE, EMBASE, PsycINFO, and ISI Web of Science and references of identified articles were searched up to June 2013 using the keywords (bipolar disorder) AND (C-reactive protein OR CRP). English language studies measuring blood levels of CRP in patients with BD and control subjects were selected, 136 abstracts were reviewed, 20 articles retrieved, and 11 studies included. Two independent reviewers extracted data. All studies were included in the primary analyses, and between-group differences for subanalyses were also reported. This meta-analysis was performed using random-effects models. Eleven studies comprising 1,618 subjects were eligible for inclusion. Overall, CRP levels were significantly elevated in patients with BD versus controls (standardized mean difference [SMD] = 0.39; 95% CI, 0.24 to 0.55; P < .0001). CRP levels were significantly higher in manic (SMD = 0.73; 95% CI, 0.44 to 1.02; P < .001) and ...Continue Reading

Associated Clinical Trials

Citations

Feb 20, 2016·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Hui Hua ChangPo See Chen
Apr 28, 2016·Nordic Journal of Psychiatry·Adam WysokińskiTomasz Kostka
Oct 30, 2016·Expert Review of Molecular Diagnostics·Antonio L TeixeiraRodrigo Machado-Vieira
Nov 9, 2016·Translational Psychiatry·N Mechawar, J Savitz
Aug 31, 2016·Annual Review of Psychology·Andrea Danese, Jessie R Baldwin
May 20, 2016·Scientific Reports·Masatoshi InoshitaTetsuro Ohmori
Apr 30, 2016·The Australian and New Zealand Journal of Psychiatry·Ole KöhlerAndrew A Nierenberg
Jan 1, 2017·European Archives of Psychiatry and Clinical Neuroscience·Viktoria JohanssonMikael Landén
Apr 20, 2016·The Australian and New Zealand Journal of Psychiatry·Bruna M AscoliAdriane Ribeiro Rosa
Apr 5, 2017·The Australian and New Zealand Journal of Psychiatry·Aroldo A DargélUNKNOWN FACE-BD collaborators
May 13, 2018·Annals of the New York Academy of Sciences·Moisés E Bauer, Antonio L Teixeira
Jan 21, 2018·International Journal of Bipolar Disorders·Wahid BoukouaciRyad Tamouza
Jan 15, 2016·International Journal of Bipolar Disorders·Monica AasBruno Etain
Dec 8, 2017·Acta Neuropsychiatrica·Ole Köhler-ForsbergAndrew Alan Nierenberg
May 20, 2016·Psychological Medicine·A F CarvalhoM Berk
Mar 19, 2016·Psychopharmacology·Marion LeboyerLaurent Groc
Aug 13, 2017·Scientific Reports·Parvin KumarCatharina Lavebratt
Dec 13, 2017·Journal of Clinical Psychopharmacology·John J Mooney, Roscoe O Brady
Oct 3, 2019·Nordic Journal of Psychiatry·Burcu Kok KendirliogluNesrin Karamustafalioglu
Feb 14, 2020·BMC Medicine·Konstantinos IoannidisAnne-Laura van Harmelen
Mar 16, 2016·Proceedings of the National Academy of Sciences of the United States of America·Qian RenKenji Hashimoto
Aug 24, 2017·Acta Psychiatrica Scandinavica·J OliveiraM Leboyer
Feb 6, 2018·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Pamela FerrariFlorencia M Barbé-Tuana
Dec 4, 2019·International Journal of Bipolar Disorders·Ann-Kristin EversSarah Kittel-Schneider
May 4, 2017·Translational Psychiatry·B E WurfelJ B Savitz
Jun 7, 2019·Acta Neuropsychiatrica·Ole Köhler-ForsbergAndrew A Nierenberg
Jun 11, 2015·Acta Psychiatrica Scandinavica·F DickersonR Yolken
Jul 20, 2016·International Journal of Bipolar Disorders·Sonya M BalukovaRobert A Schoevers
Mar 17, 2020·Frontiers in Psychiatry·Francesco BenedettiRoberto Furlan
Oct 21, 2016·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Andrea Danese, Stephanie J Lewis
Jul 7, 2015·PloS One·Sarven SabunciyanRobert H Yolken
Nov 26, 2020·European Psychiatry : the Journal of the Association of European Psychiatrists·Marc Østergaard NielsenLars Vedel Kessing
Dec 10, 2020·Journal of Affective Disorders·Rodrigo B MansurRoger S McIntyre
Jan 12, 2021·Development and Psychopathology·Brie Reid, Andrea Danese

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.